"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor ...

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Few differences were found for cardiovascular, kidney, and mortality outcomes between liraglutide, semaglutide, and dulaglutide for patients with type 2 diabetes.

In this comparative effectiveness study in veterans with diabetes, liraglutide, semaglutide, and dulaglutide initiators had similar risks for kidney and cardiovascular outcomes. Head-to-head ...

In a Naples clinic, an unexpected link between a diabetes medication and relief from migraines has caused a stir in the medical community. Researchers at discovered that the diabetes and ...

Discover how FTIR spectroscopy enhances quality control in GLP-1 weight loss drug production by ensuring molecular ...

At first glance, Ozempic and Wegovy seem like miracle drugs of the 21st century — a pair of injections that shrink waistlines ...

A new method of taking microscopic images of a live mouse's retina through the eye allows researchers to record the reaction ...